Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Frystyk

Showing results (151-160 of 292) with videos related to

Pageof 30
Sort By:
The American Journal of Cardiology|February 5, 2013
Relation of serum adiponectin levels to number of traditional atherosclerotic risk factors and all-cause mortality and major adverse cardiovascular events (from the Copenhagen City Heart Study)Soren Lindberg, Rasmus Mogelvang, Sune H Pedersen, et al.
The Journal of Clinical Endocrinology and Metabolism|October 23, 2009
The role of insulin-like growth factor (IGF) binding protein-2 in the insulin-mediated decrease in IGF-I bioactivityAyman M Arafat, Martin O Weickert, Jan Frystyk, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|October 28, 2006
The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRTClaus Højbjerg Gravholt, Jian-Wen Chen, Claus Oxvig, et al.
Diabetes Care|August 1, 2014
Low adiponectin levels and increased risk of type 2 diabetes in patients with myocardial infarctionSøren Lindberg, Jan S Jensen, Sune H Pedersen, et al.
European Journal of Endocrinology|November 2, 2013
Serum levels of bioactive IGF1 and physiological markers of ageing in healthy adultsPoul Frølund Vestergaard, Mette Hansen, Jan Frystyk, et al.
American Journal of Hypertension|January 10, 2025
Obese Hypertensive Men Have Fasting Serum Concentrations of Leptin Similar to Those of Obese Normotensive MenCamilla L Asferg, Ulrik B Andersen, Jan Frystyk, et al.
Diabetes Research and Clinical Practice|October 27, 2023
Associations between insulin-like growth factor binding protein-2 and insulin sensitivity, metformin, and mortality in persons with T2DRikke Hjortebjerg, Maja R Kristiansen, Ivan Brandslund, et al.
The Journal of Clinical Endocrinology and Metabolism|August 4, 2005
Pioglitazone treatment increases spontaneous growth hormone (GH) secretion and stimulated GH levels in polycystic ovary syndromeDorte Glintborg, René Klinkby Støving, Claus Hagen, et al.
Ugeskrift for Laeger|March 16, 2007
[Medical co-treatment af acromegaly with a somatostatin analogue and a growth hormone receptor antagonist]Jens Otto Lunde Jørgensen, Ulla Feldt-Rasmussen, Jan Frystyk, et al.
Clinical Nutrition (Edinburgh, Scotland)|May 1, 2012
Changes in adipokines after transjugular intrahepatic porto-systemic shunt indicate an anabolic shift in metabolismKaren Louise Thomsen, Thomas Damgaard Sandahl, Peter Holland-Fischer, et al.
Pageof 30

Showing results (151-160 of 292) with videos related to

Sort By:
Pageof 30
The American Journal of Cardiology|February 5, 2013
Relation of serum adiponectin levels to number of traditional atherosclerotic risk factors and all-cause mortality and major adverse cardiovascular events (from the Copenhagen City Heart Study)Soren Lindberg, Rasmus Mogelvang, Sune H Pedersen, et al.
The Journal of Clinical Endocrinology and Metabolism|October 23, 2009
The role of insulin-like growth factor (IGF) binding protein-2 in the insulin-mediated decrease in IGF-I bioactivityAyman M Arafat, Martin O Weickert, Jan Frystyk, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|October 28, 2006
The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRTClaus Højbjerg Gravholt, Jian-Wen Chen, Claus Oxvig, et al.
Diabetes Care|August 1, 2014
Low adiponectin levels and increased risk of type 2 diabetes in patients with myocardial infarctionSøren Lindberg, Jan S Jensen, Sune H Pedersen, et al.
European Journal of Endocrinology|November 2, 2013
Serum levels of bioactive IGF1 and physiological markers of ageing in healthy adultsPoul Frølund Vestergaard, Mette Hansen, Jan Frystyk, et al.
American Journal of Hypertension|January 10, 2025
Obese Hypertensive Men Have Fasting Serum Concentrations of Leptin Similar to Those of Obese Normotensive MenCamilla L Asferg, Ulrik B Andersen, Jan Frystyk, et al.
Diabetes Research and Clinical Practice|October 27, 2023
Associations between insulin-like growth factor binding protein-2 and insulin sensitivity, metformin, and mortality in persons with T2DRikke Hjortebjerg, Maja R Kristiansen, Ivan Brandslund, et al.
The Journal of Clinical Endocrinology and Metabolism|August 4, 2005
Pioglitazone treatment increases spontaneous growth hormone (GH) secretion and stimulated GH levels in polycystic ovary syndromeDorte Glintborg, René Klinkby Støving, Claus Hagen, et al.
Ugeskrift for Laeger|March 16, 2007
[Medical co-treatment af acromegaly with a somatostatin analogue and a growth hormone receptor antagonist]Jens Otto Lunde Jørgensen, Ulla Feldt-Rasmussen, Jan Frystyk, et al.
Clinical Nutrition (Edinburgh, Scotland)|May 1, 2012
Changes in adipokines after transjugular intrahepatic porto-systemic shunt indicate an anabolic shift in metabolismKaren Louise Thomsen, Thomas Damgaard Sandahl, Peter Holland-Fischer, et al.
Pageof 30